A livello globale, e in particolare nelle nazioni sviluppate, si è verificata una tendenza al rialzo nell'età media delle neomamme. Questo cambiamento è attribuito a vari fattori, tra cui le donne che perseguono un'istruzione superiore e opportunità di carriera, il ritardo del matrimonio e la crescente accettazione delle donne non sposate che diventano madri. Poiché sempre più coppie si rivolgono ai trattamenti per la fertilità per concepire, la domanda di servizi di fecondazione in vitro (FIV) è in aumento. Di conseguenza, si prevede che il mercato della fecondazione in vitro crescerà durante il periodo di previsione, spinto dall'aumento dell'età media delle neomamme.
| ATTRIBUTO | DETTAGLI |
| Periodo di studio | 2020-2029 |
| Anno base | 2021 |
| Anno stimato | 2022 |
| Anno previsto | 2022-2029 |
| Periodo storico | 2018-2020 |
| Unità | Valore (milioni di USD) |
| Segmentazione | Per prodotto, per tipo di ciclo, per utenti finali, per regione |
| Per Prodotto |
|
| Per tipo di ciclo |
|
| Da parte degli utenti finali |
|
| Per regione |
|
Nei prossimi anni, il mercato della fecondazione in vitro è pronto per una significativa espansione, in gran parte dovuta all'aumento del turismo medico tra le economie emergenti. La propensione dei pazienti odierni a viaggiare all'estero alla ricerca di servizi sanitari superiori ha dato origine a un'industria fiorente nota come turismo medico. Con una tecnologia medica avanzata facilmente accessibile e trattamenti offerti a prezzi accessibili, i pazienti dei paesi in via di sviluppo preferiscono cercare assistenza sanitaria nei paesi sviluppati. La fecondazione in vitro sta guadagnando popolarità tra le coppie nelle economie emergenti, stimolando così la crescita del mercato. Inoltre, si prevede che una maggiore consapevolezza della disponibilità di trattamenti per la fertilità e la proliferazione di cliniche e ospedali per l'infertilità contribuiranno alla traiettoria di crescita del mercato nei prossimi anni.
Efforts by governments and various organizations to launch educational campaigns aimed at informing the public about fertility care, treatment options, and factors influencing infertility are on the rise. For instance, in August 2022, Pinnacle Fertility initiated the Save IVF campaign to raise awareness about potential new legislation threatening family-building treatments. Similarly, in July 2022, Oasis Fertility launched the Infertility Knows No Gender campaign in commemoration of World IVF Day. IVF stands as a beacon of hope for millions of couples grappling with infertility.
The In-Vitro Fertilization (IVF) market size had crossed USD 584.78 Million in 2020 and will observe a CAGR of more than 9.1 % up to 2027 driven by the increase in the median age of first-time mothers, declining fertility rates, rising male fertility, increased public awareness about fertility and treatments.
Asia Pacific held more than 41% of the In-Vitro Fertilization (IVF) market revenue share in 2020 and will witness expansion with the healthcare infrastructure and rising medical tourism in Asian countries along with, rising healthcare expenditure and growing awareness of infertility among people.
The upcoming trends in In-Vitro Fertilization (IVF) market are techniques such as testicular sperm extraction (PESA and TESE) and the development of new products to increase the success rate of IVF.
Key players profiled in the report include The Cooper Companies Inc., Cook Group, Vitrolife, Thermo Fisher Scientific, Inc., Esco Micro Pte. Ltd., Genea Limited, IVFtech ApS, FUJIFILM Irvine Scientific, The Baker Company, Inc., Kitazato Corporation, Corning Corporation, Hamilton Thorne Ltd., ZEISS Group, FERTIPRO NV, and Eppendorf.
Women's pregnancies being delayed and global infertility rates rising will assist the accelerated growth in the near future.
With a CAGR of 10.1 percent over the projection period, Asia Pacific is the fastest-growing regional category in the in vitro fertilization market. This is due to increased medical tourism in Asian countries, rising healthcare expenditure, rising use of assisted reproductive technology in emerging countries, and rising public awareness of IVF therapy, all of which are contributing to the region's in vitro fertilization market growth.
The global in vitro fertilization (IVF) market is segmented based on product, cycle type, end users. By product, the market is bifurcated into micromanipulators, incubators, cabinets, imaging system, laser system, reagents & accessories. During the forecast period, the equipment segment is expected to grow at the fastest rate. The high growth in this is due to the increasing number of IVF procedures and the introduction of highly advanced IVF equipment by market-leading manufacturers.
By cycle type, the market is divided into fresh IVF cycles, thawed IVF cycles, donor egg IVF cycles. Fresh IVF cycles (non-donor) accounted for the majority of revenue, and this trend is expected to continue during the forecast period, owing to higher success rates, as fresh embryo transfers result in higher pregnancy and birth rates compared to those who received frozen embryos.
By end user, the market is segmented into fertility clinics, hospitals, cryobanks. In 2021, the fertility clinics segment dominated the IVF market, accounting for more than 79.0 percent of revenue. From 2022 to 2030, the segment is expected to grow at the fastest rate. With an increase in demand for ART treatments, the number of fertility clinics and ART centres is rapidly increasing. Cost-effectiveness, availability of specialists, and low or no risk of Hospital-acquired Infections (HAIs) are expected to drive the growth of fertility clinics. Hospitals also provide IVF treatments.
[caption id="attachment_6736" align="alignleft" width="680"]
The in vitro fertilization (IVF) market key players include The Cooper Companies Inc., Cook Group, Vitrolife, Thermo Fisher Scientific, Inc., Esco Micro Pte. Ltd., Genea Limited, IVFtech ApS, FUJIFILM Irvine Scientific, The Baker Company, Inc., Kitazato Corporation, Corning Corporation, Hamilton Thorne Ltd., ZEISS Group, FERTIPRO NV, and Eppendorf.
For corporate expansion, these key leaders are implementing strategic formulations such as new product development and commercialization, commercial expansion, and distribution agreements. Moreover, these participants are substantially spending in product development, which is fueling revenue generation.
The in vitro fertilization (IVF) market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
Asia Pacific is the market leader in in vitro fertilization. Significant increase in medical tourism, increased awareness of the availability of in vitro fertilization procedures, decreased IVF treatment procedures, growing fertility clinics in the region, rising healthcare expenditures, and increasing adoption of assisted reproductive technology in emerging nations. Expansion of healthcare infrastructure and increase in disposable personal income, rising medical tourism in Asian countries, rising healthcare expenditure, and growing awareness of infertility among people all contribute to the region's in vitro fertilization market growth.
[caption id="attachment_6737" align="alignleft" width="680"]
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.